Geneos Wealth Management Inc. Sells 773 Shares of Aflac Incorporated (NYSE:AFL)

Posted by Defense World Staff on Apr 14th, 2023

Geneos Wealth Management Inc. reduced its stake in shares of Aflac Incorporated (NYSE:AFL – Get Rating) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,392 shares of the financial services provider’s stock after selling 773 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Aflac were worth $891,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of AFL. Panagora Asset Management Inc. grew its stake in shares of Aflac by 36.2% during the first quarter. Panagora Asset Management Inc. now owns 23,941 shares of the financial services provider’s stock valued at $1,542,000 after buying an additional 6,369 shares during the last quarter. Blair William & Co. IL lifted its holdings in shares of Aflac by 6.8% during the first quarter. Blair William & Co. IL now owns 17,268 shares of the financial services provider’s stock valued at $1,112,000 after purchasing an additional 1,102 shares during the last quarter. Aviva PLC lifted its holdings in shares of Aflac by 0.7% during the first quarter. Aviva PLC now owns 210,634 shares of the financial services provider’s stock valued at $13,563,000 after purchasing an additional 1,503 shares during the last quarter. Dakota Wealth Management purchased a new position in shares of Aflac during the first quarter valued at approximately $428,000. Finally, Sequoia Financial Advisors LLC lifted its holdings in shares of Aflac by 7.3% during the first quarter. Sequoia Financial Advisors LLC now owns 6,142 shares of the financial services provider’s stock valued at $396,000 after purchasing an additional 417 shares during the last quarter. 66.22% of the stock is owned by institutional investors.

Aflac Trading Up 0.5 %

Shares of AFL stock opened at $66.30 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. The stock has a fifty day simple moving average of $66.24 and a two-hundred day simple moving average of $67.28. The firm has a market capitalization of $40.59 billion, a PE ratio of 10.09, a PEG ratio of 2.33 and a beta of 0.93. Aflac Incorporated has a 52-week low of $52.07 and a 52-week high of $74.01.

Aflac (NYSE:AFL – Get Rating) last released its earnings results on Thursday, February 2nd. The financial services provider reported $1.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.08. Aflac had a return on equity of 13.69% and a net margin of 21.54%. The firm had revenue of $4.01 billion during the quarter, compared to analysts’ expectations of $4.49 billion. During the same quarter last year, the business posted $1.28 earnings per share. The firm’s revenue was down 26.2% on a year-over-year basis. On average, analysts predict that Aflac Incorporated will post 5.59 EPS for the current fiscal year.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 500 shares of Aflac stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $64.45, for a total value of $32,225.00. Following the sale, the director now directly owns 19,269 shares of the company’s stock, valued at $1,241,887.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Masatoshi Koide sold 19,291 shares of Aflac stock in a transaction that occurred on Tuesday, February 14th. The stock was sold at an average price of $70.36, for a total value of $1,357,314.76. Following the completion of the transaction, the director now owns 87,598 shares in the company, valued at approximately $6,163,395.28. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 500 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $64.45, for a total value of $32,225.00. Following the transaction, the director now directly owns 19,269 shares in the company, valued at approximately $1,241,887.05. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Raymond James lifted their target price on shares of Aflac from $74.00 to $77.00 and gave the company an “outperform” rating in a report on Monday, January 30th. JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $62.00 to $66.00 and gave the stock a “neutral” rating in a report on Friday, January 6th. Truist Financial boosted their price objective on shares of Aflac from $65.00 to $70.00 and gave the stock a “hold” rating in a report on Monday, February 6th. StockNews.com assumed coverage on shares of Aflac in a report on Thursday, March 16th. They issued a “hold” rating for the company. Finally, Morgan Stanley decreased their price objective on shares of Aflac from $77.00 to $72.00 and set an “overweight” rating for the company in a report on Wednesday. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $71.13.

Aflac Company Profile

(Get Rating)

Aflac, Inc is a holding company. engages in the provision of financial protection services. It operates through the followings segments: Aflac Japan and Aflac United States (U.S.). The Aflac Japan segment offers life insurance, death benefits, and cash surrender values. The Aflac U.S. segment sells voluntary supplemental insurance products for people who already have major medical or primary insurance coverage.